Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX)

CUSIP: 36338D108

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
75,462,362
Total 13F shares
18,666,881
Share change
+6,684,929
Total reported value
$47,787,096
Put/Call ratio
0.46%
Price per share
$2.56
Number of holders
38
Value change
+$17,178,135
Number of buys
24
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 36338D108?
CUSIP 36338D108 identifies GRTX - Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q1 2023

As of 31 Mar 2023, Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,666,881 shares. The largest 10 holders included Sofinnova Investments, Inc., Alyeska Investment Group, L.P., Novo Holdings A/S, SECTORAL ASSET MANAGEMENT INC, Blackstone Inc., VANGUARD GROUP INC, Velan Capital Investment Management LP, Tekla Capital Management LLC, UBS OCONNOR LLC, and Nan Fung Group Holdings Ltd. This page lists 38 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.